Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis
2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
2023-12-04 21:05
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS
2023-12-04 21:00
MeltMed® Rings in the Holidays with Reduced Pricing and New NAD+ Starter Packs
2023-12-04 15:01
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics
2023-12-04 13:19
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS
2023-12-01 21:00
So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business
2023-12-01 18:00
GC Biopharma establishes mRNA production facility in Hwasun, Korea
2023-12-01 16:31
Registrational Phase III CLARIFY trial in prostate cancer commences
2023-11-30 22:16
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging
2023-11-30 22:10
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
2023-11-30 21:59
CABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formula
2023-11-30 21:00
The Best Class 4 Laser Therapy Machine Takes Center Stage at The 55th Dusseldorf International Hospital and Medical Equipment Exhibition in 2023
2023-11-30 20:40
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023
2023-11-30 20:30
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
2023-11-30 14:00
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
2023-11-29 21:58
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
2023-11-29 21:00
Zhang Yu with Tencent Health: AI-Driven Customer Interaction Solution NGES Effectively Supports Pharmaceutical Enterprises' Smart Operations
2023-11-29 17:49
magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases
2023-11-29 14:06
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
2023-11-29 04:01
1
60
61
62
63
64
800